Zavori, L.; Molnar, T.; Varnai, R.; Kanizsai, A.; Nagy, L.; Vadkerti, B.; Szirmay, B.; Schwarcz, A.; Csecsei, P.
Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome. J. Pers. Med. 2023, 13, 371.
https://doi.org/10.3390/jpm13020371
AMA Style
Zavori L, Molnar T, Varnai R, Kanizsai A, Nagy L, Vadkerti B, Szirmay B, Schwarcz A, Csecsei P.
Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome. Journal of Personalized Medicine. 2023; 13(2):371.
https://doi.org/10.3390/jpm13020371
Chicago/Turabian Style
Zavori, Laszlo, Tihamer Molnar, Reka Varnai, Andrea Kanizsai, Lajos Nagy, Bence Vadkerti, Balazs Szirmay, Attila Schwarcz, and Peter Csecsei.
2023. "Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome" Journal of Personalized Medicine 13, no. 2: 371.
https://doi.org/10.3390/jpm13020371
APA Style
Zavori, L., Molnar, T., Varnai, R., Kanizsai, A., Nagy, L., Vadkerti, B., Szirmay, B., Schwarcz, A., & Csecsei, P.
(2023). Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome. Journal of Personalized Medicine, 13(2), 371.
https://doi.org/10.3390/jpm13020371
